0B68 McCue, Peter A. - Thomas Jefferson University - Thomas Jefferson University
pxm129

Peter A. McCue, MD

Contact Dr. McCue

132 S. 10th Street
Main Building, Suite 285
Philadelphia, PA 19107

(215) 955-5588

Most Recent Peer-reviewed Publications

  1. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
  2. A systematic immunohistochemical study of 3215 cases
  3. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth
  4. GATA3: A multispecific but potentially useful marker in surgical pathology: A systematic analysis of 2500 epithelial and nonepithelial tumors
  5. Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms
  6. Targeting cell cycle and hormone receptor pathways in cancer
  7. Pharmacologic inhibition of Jak2-Stat5 signaling by Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer
  8. Sarcoidosis mimicking metastatic bone disease in head and neck cancer
  9. STAT5A/B gene locus undergoes amplification during hu 05B4 man prostate cancer progression
  10. Molecular diagnosis of prostate cancer: Are we up to age?
  11. Aberrant BAF57 signaling facilitates prometastatic phenotypes
  12. Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures
  13. Dual roles of PARP-1 promote cancer 05B4 growth and progression
  14. Knockdown of Ki-67 by Dicer-Substrate Small Interfering RNA Sensitizes Bladder Cancer Cells to Curcumin-Induced Tumor Inhibition
  15. Contrast enhanced transrectal ultrasound for the detection of prostate cancer: A randomized, double-blind trial of dutasteride pretreatment
  16. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis
  17. Renal medullary carcinomas: Histopathologic phenotype associated with diverse genotypes
  18. Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells
  19. Comparison of lymph node yield in robot-assisted laparoscopic prostatectomy with that in open radical retropubic prostatectomy
  20. Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation
0